2023 - Research.com Biology and Biochemistry in New Zealand Leader Award
His primary areas of investigation include Myeloid leukemia, Leukemia, Cancer research, Genetics and Molecular biology. The Midostaurin research Stefan K. Bohlander does as part of his general Myeloid leukemia study is frequently linked to other disciplines of science, such as Autophosphorylation, therefore creating a link between diverse domains of science. His studies deal with areas such as Myeloid, RUNX1 Translocation Partner 1 Protein, Fms-Like Tyrosine Kinase 3 and Stem cell as well as Leukemia.
His work carried out in the field of Cancer research brings together such families of science as Haematopoiesis, Granulopoiesis, CEBPA, Ccaat-enhancer-binding proteins and K562 cells. He focuses mostly in the field of Genetics, narrowing it down to topics relating to Osteogenesis imperfecta and, in certain cases, Mutation and Silent mutation. The concepts of his Molecular biology study are interwoven with issues in Chromosomal translocation, ABL, Fluorescence in situ hybridization, Molecular cloning and Multiplex ligation-dependent probe amplification.
The scientist’s investigation covers issues in Myeloid leukemia, Cancer research, Molecular biology, Leukemia and Genetics. His Myeloid leukemia research is multidisciplinary, incorporating elements of Stem cell, Oncology and Gene expression profiling. His Cancer research research integrates issues from Mutation, microRNA, CDX2, RUNX1 and Regulation of gene expression.
The Molecular biology study combines topics in areas such as ETV6, Chromosomal translocation, Fusion gene, Gene cluster and Fluorescence in situ hybridization. His research in Leukemia tackles topics such as Myeloid which are related to areas like Progenitor cell. His research integrates issues of Acute lymphocytic leukemia and ABL in his study of Gene.
Myeloid leukemia, Cancer research, Leukemia, Internal medicine and Myeloid are his primary areas of study. His Myeloid leukemia research includes elements of Exome sequencing, Proto-Oncogene Proteins, Function and Anti proliferative. Stefan K. Bohlander has included themes like Tumor hypoxia, Stem cell and Gene, Somatic cell in his Cancer research study.
His Gene study is related to the wider topic of Genetics. His Leukemia study is concerned with the field of Immunology as a whole. The various areas that he examines in his Myeloid study include Mutation, CEBPA, Transcriptome, RUNX1 and RUNX1T1.
His main research concerns Leukemia, Cancer research, Myeloid leukemia, Myeloid and Internal medicine. Leukemia is a subfield of Immunology that he tackles. His research in Cancer research focuses on subjects like Gene, which are connected to Surrogate endpoint.
His Myeloid leukemia study integrates concerns from other disciplines, such as Bioinformatics, Real-time polymerase chain reaction, DNA microarray, Computational biology and Induction chemotherapy. His research on Myeloid also deals with topics like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Stem cell gene expression programs influence clinical outcome in human leukemia
Kolja Eppert;Katsuto Takenaka;Eric R Lechman;Levi Waldron.
Nature Medicine (2011)
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia
T R Golub;G F Barker;S K Bohlander;S W Hiebert.
Proceedings of the National Academy of Sciences of the United States of America (1995)
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia
Shuangli Mi;Jun Lu;Jun Lu;Miao Sun;Zejuan Li.
Proceedings of the National Academy of Sciences of the United States of America (2007)
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations
Zejuan Li;Jun Lu;Jun Lu;Miao Sun;Shuangli Mi.
Proceedings of the National Academy of Sciences of the United States of America (2008)
The MLL recombinome of acute leukemias in 2013
C. Meyer;J. Hofmann;T. Burmeister;D. Gröger.
Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia.
T. R. Golub;A. Goga;G. F. Barker;D. E. H. Afar.
Molecular and Cellular Biology (1996)
Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic.
Francesc Tebar;Stefan K. Bohlander;Alexander Sorkin.
Molecular Biology of the Cell (1999)
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.
Klaus H. Metzeler;Manuela Hummel;Clara D. Bloomfield;Karsten Spiekermann.
Acute Myeloid Leukemia With Biallelic CEBPA Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome
Annika Dufour;Friederike Schneider;Klaus H. Metzeler;Eva Hoster.
Journal of Clinical Oncology (2010)
Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias.
Jennifer A. Pietenpol;Stefan K. Bohlander;Yuko Sato;Nickolas Papadopoulos.
Cancer Research (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: